CoChat

NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition

Open access
Garcia-Rendueles, Maria E.R., Ricarte-Filho, Julio C., Untch, Brian R., Landa, Iňigo, Knauf, Jeffrey A., Voza, Francesca, Smith, Vicki E., Ganly, Ian, Taylor, Barry S., Persaud, Yogindra, Oler, Gisele, Fang, Yuqiang, Jhanwar, Suresh C., Viale, Agnes, Heguy, Adriana, Huberman, Kety H., Giancotti, Filippo, Ghossein, Ronald, Fagin, James A. · 2015 · Cancer Discovery
Cited by 138

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Ch22q LOH is preferentially associated with RAS mutations in papillary and in poorly differentiated thyroid cancer (PDTC). The 22q tumor suppressor NF2, encoding merlin, is implicated in this interaction because of its frequent loss of function in human thyroid cancer cell lines. Nf2 deletion or Hras mutation is insufficient for transformation, whereas their combined disruption leads to murine PDTC with increased MAPK signaling. Merlin loss induces RAS signaling in part through inactivation of Hippo, which activates a YAP–TEAD transcriptional program. We find that the three RAS genes are themselves YAP–TEAD1 transcriptional targets, providing a novel mechanism of promotion of RAS-induced tumorigenesis. Moreover, pharmacologic disruption of YAP–TEAD with verteporfin blocks RAS transcription and signaling and inhibits cell growth. The increased MAPK output generated by NF2 loss in RAS-mutant cancers may inform therapeutic strategies, as it generates greater dependency on the MAPK pathway for viability. Significance: Intensification of mutant RAS signaling through copy-number imbalances is commonly associated with transformation. We show that NF2/merlin inactivation augments mutant RAS signaling by promoting YAP/TEAD-driven transcription of oncogenic and wild-type RAS, resulting in greater MAPK output and increased sensitivity to MEK inhibitors. Cancer Discov; 5(11); 1178–93. ©2015 AACR. This article is highlighted in the In This Issue feature, p. 1111

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-15-0330

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 138

Metadata

Authors
Garcia-Rendueles, M. E. R., Ricarte-Filho, J. C., Untch, B. R., Landa, I., Knauf, J. A., Voza, F., Smith, V. E., Ganly, I., Taylor, B. S., Persaud, Y., Oler, G., Fang, Y., Jhanwar, S. C., Viale, A., Heguy, A., Huberman, K. H., Giancotti, F., Ghossein, R., & Fagin, J. A.
Venue
Cancer Discovery
Published
2015-11-01
Volume
5
Issue
11
Pages
1178-1193
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W2120396011
Cited by
138
References
10
FWCI
6.78
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition. https://app.cochat.ai/papers/10.1158/2159-8290.cd-15-0330
The paper
Garcia-Rendueles, M. E. R., Ricarte-Filho, J. C., Untch, B. R., Landa, I., Knauf, J. A., Voza, F., Smith, V. E., Ganly, I., Taylor, B. S., Persaud, Y., Oler, G., Fang, Y., Jhanwar, S. C., Viale, A., Heguy, A., Huberman, K. H., Giancotti, F., Ghossein, R., & Fagin, J. A. (2015). NF2 Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-15-0330

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.